id898.html
In development: Guidance, quality standards and advice
Thu, 27 Feb 2025 00:35:00 GMT
prophylactic removal [ID898] Technology appraisal guidance TBC Tislelizumab for treating advanced non-small-cell lung cancer after platinum-based chemotherapy ID6161 Technology appraisal guidance TBC ...